Pricing

Fresh Tracks Therapeutics Inc (FRTX)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Robert B. Brown
Employees:
20
5777 CENTRAL AVENUE, SUITE 102, BOULDER, CO, 80301
(720) 505-4755
    Formally known as:
  • BRICKELL BIOTECH ORD SHS
Stock Split History
DateRatio
2016-05-27 1:10
2019-09-03 1:7
2022-07-05 1:45
Brickell Biotech, Inc. engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofironium bromide, which has completed Phase III clinical trials for the. treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor, and BBI10, a covalent stimulator of interferon genes inhibitor.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available